澳股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

RACE ONCOLOGY LTD

2.000

0.000

成交量：3.26萬

成交額：6.48萬

市值：3.92億

市盈率：-32.31

高：2.000

開：1.985

低：1.960

收：2.000

52周最高：4.900

52周最低：1.910

股本：1.96億

流通股本：1.21億

量比：0.36

換手率：0.03%

股息：- -

股息率：- -

每股收益(TTM):-0.062

每股收益(LYR):-0.062

淨資產收益率：-42.28%

總資產收益率：-23.40%

市淨率：10.76

市盈率(LYR):-32.31

資料載入中...

總覽公司新聞資訊公告

概念

醫藥生物股+1.18%

資金流向

資金流入：

資金流出：

新聞資訊

Racura Oncology通過配售與跟投及獎勵期權資金，籌集3120萬美元支持RC220臨床開發

瑞庫拉腫瘤學宣佈CPACS臨床試驗獲得安全審查委員會積極推薦

Racura Oncology 宣佈Cpacs臨床試驗獲安全審查委員會積極建議

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"老虎國際,美股交易,港股交易,交易美股,股票信息,股價,美股行情,美股打新,港股打新,IPO打新,購買美股,全球投資","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/hant/stock/RAC.AU"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"RAC.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"RAC.AU\",,,,,undefined,":{"symbol":"RAC.AU","market":"AU","secType":"STK","nameCN":"RACE ONCOLOGY LTD","latestPrice":2,"timestamp":1789452720000,"preClose":2,"halted":0,"volume":32610,"delay":0,"changeRate":0,"nameEN":"RACE ONCOLOGY LTD","floatShares":121205750,"shares":196068940,"eps":-0.0619,"marketStatus":"未開盤","change":0,"latestTime":"09-15 16:12:00 AEST","open":1.985,"high":2,"low":1.96,"amount":64758,"amplitude":0.02,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.0619,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":0,"beginTime":1789516800000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":2,"openAndCloseTimeList":[[1789430400000,1789452000000]],"volumeRatio":0.3637852409740076,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"RAC.AU","preClose":2,"auctionPrice":2,"auctionVolume":302,"auction":3,"marketStatus":"盘后竞价","timestamp":1789452601597}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"RAC.AU\",,,,,undefined,":{"symbol":"RAC.AU","floatShares":121205750,"roa":"-23.40%","roe":"-42.28%","lyrEps":-0.0619,"volumeRatio":0.3637852409740076,"shares":196068940,"dividePrice":0,"high":2,"amplitude":0.02,"preClose":2,"low":1.96,"week52Low":1.91,"pbRate":"10.76","psRate":"139.50","week52High":4.9,"institutionHeld":0,"latestPrice":2,"eps":-0.0619,"divideRate":0,"volume":32610,"delay":0,"ttmEps":-0.0619,"open":1.985,"prevYearClose":2.73,"prevWeekClose":2.02,"prevMonthClose":2.13,"prevQuarterClose":2.22,"fiveDayClose":2.13,"twentyDayClose":2.12,"sixtyDayClose":2.38},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/RAC.AU\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"RAC.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"RAC.AU\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1168425417","title":"Racura Oncology通過配售與跟投及獎勵期權資金，籌集3120萬美元支持RC220臨床開發","url":"https://stock-news.laohu8.com/highlight/detail?id=1168425417","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1168425417?lang=zh_tw&edition=fundamental","pubTime":"2026-06-04 06:53","pubTimestamp":1780527198,"startTime":"0","endTime":"0","summary":"Racura Oncology宣布，公司通过股权配售，并结合跟投与奖励期权计划所获资金，成功筹集了总计3120万美元。这笔资金将专项用于支持其候选药物RC220的临床开发项目。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7067","BK7508","RAC.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1149868178","title":"瑞庫拉腫瘤學宣佈CPACS臨床試驗獲得安全審查委員會積極推薦","url":"https://stock-news.laohu8.com/highlight/detail?id=1149868178","media":"投资观察","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1149868178?lang=zh_tw&edition=fundamental","pubTime":"2026-05-15 19:23","pubTimestamp":1778844180,"startTime":"0","endTime":"0","summary":"瑞库拉肿瘤学有限公司宣布，其正在进行的CPACS临床试验获得了安全审查委员会的积极推荐。\n瑞库拉肿瘤学有限公司指出，在第一队列中，单独使用RC220或与多柔比星联合使用均未发现安全性问题。\n瑞库拉肿瘤学有限公司表示，将在80毫克/平方米的RC220剂量水平上，启动第二队列患者的筛选工作。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","RAC.AU","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1108465491","title":"Racura Oncology 宣佈Cpacs臨床試驗獲安全審查委員會積極建議","url":"https://stock-news.laohu8.com/highlight/detail?id=1108465491","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1108465491?lang=zh_tw&edition=fundamental","pubTime":"2026-05-15 19:08","pubTimestamp":1778843295,"startTime":"0","endTime":"0","summary":"Racura Oncology宣布，其正在进行的Cpacs临床试验已获得安全审查委员会的积极建议，标志着该研究的一个重要进展。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RAC.AU","BK7067","BK7508"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":1,"pageCount":1,"totalSize":3,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/RAC.AU\",params:#limit:6,delay:true,,,undefined,":[{"market":"AU","name":"醫藥生物股","id":"package_au_concept_yyswg","bkCode":"BK7508","changeRate":0.011805}]}}